Title : Neprilysin expression and functions in development, ageing and disease.

Pub. Date : 2020 Dec

PMID : 32987038






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This prevents development of pharmacological treatments from various diseases in which NEP is implicated although recently a dual-acting drug sacubitril-valsartan (LCZ696) combining a NEP inhibitor and angiotensin receptor blocker has been approved for treatment of heart failure. Valsartan membrane metalloendopeptidase Homo sapiens
2 This prevents development of pharmacological treatments from various diseases in which NEP is implicated although recently a dual-acting drug sacubitril-valsartan (LCZ696) combining a NEP inhibitor and angiotensin receptor blocker has been approved for treatment of heart failure. Valsartan membrane metalloendopeptidase Homo sapiens